Works by Henley, David


Results: 72
    1
    2
    3
    4
    5
    6

    BOOK REVIEWS.

    Published in:
    2006
    By:
    • Garnaut, Ross;
    • Nashihin, Muhammad;
    • Peluso, Nancy;
    • Cooper, Richard N.;
    • Machmud, T. M. Arief;
    • Resosudarmo, Budy P.;
    • Vidyattama, Yogi;
    • Henley, David;
    • Thomas Lindblad, J.;
    • Steele, Janet
    Publication type:
    Book Review
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 3, p. 827, doi. 10.1210/jc.2005-1862
    By:
    • Benn, Diana E.;
    • Gimenez-Roqueplo, Anne-Paule;
    • Reilly, Jennifer R.;
    • Bertherat, Je´roˆme;
    • Burgess, John;
    • Byth, Karen;
    • Croxson, Michael;
    • Dahia, Patricia L. M.;
    • Elston, Marianne;
    • Gimm, Oliver;
    • Henley, David;
    • Herman, Philippe;
    • Murday, Victoria;
    • Niccoli-Sire, Patricia;
    • Pasieka, Janice L.;
    • Rohmer, Vincent;
    • Tucker, Kathy;
    • Jeunemaitre, Xavier;
    • Marsh, Deborah J.;
    • Plouin, Pierre-Franc¸ois
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Views and perceptions of amyloid imaging in a preclinical Alzheimer's disease trial.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080576
    By:
    • Ritchie, Marina;
    • Raman, Rema;
    • Ernstrom, Karin;
    • Wang, Shunran;
    • Donohue, Michael C.;
    • Aisen, Paul S. S;
    • Henley, David;
    • Romano, Gary;
    • Novak, Gerald P;
    • Brashear, H. Robert;
    • Sperling, Reisa A.;
    • Grill, Joshua D.
    Publication type:
    Article
    34
    35
    36
    37
    38

    FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P873, doi. 10.1016/j.jalz.2019.06.4621
    By:
    • Henley, David;
    • Sperling, Reisa A.;
    • Aisen, Paul S.;
    • Raman, Rema;
    • Donohue, Michael C.;
    • Ernstrom, Karin;
    • Shi, Yingqi;
    • Karcher, Keith;
    • Raghavan, Nandini;
    • Tymofyeyev, Yevgen;
    • Brashear, Robert;
    • Novak, Gerald P.;
    • Thipphawong, John;
    • Saad, Ziad;
    • Kolb, Hartmuth C.;
    • Romano, Gary
    Publication type:
    Article
    39

    EXPLORING THE UTILITY OF CSF NEUROGRANIN LEVELS IN AN ALZHEIMER’S DISEASE CLINICAL TRIAL.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1062, doi. 10.1016/j.jalz.2016.06.2218
    By:
    • Dage, Jeffrey L.;
    • Castelluccio, Peter F.;
    • Anderson, Wesley;
    • Yu, Peng;
    • Talbot, Jayne;
    • Miller, Bradley B.;
    • Herries, Elizabeth M.;
    • Crimmins, Dan;
    • Ladenson, Jack H.;
    • Fagan, Anne M.;
    • Holtzman, David M.;
    • Henley, David B.;
    • Siemers, Eric R.;
    • Dean, Robert A.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    49

    Canadian Maritime Law Update: 2009.

    Published in:
    Journal of Maritime Law & Commerce, 2010, v. 41, n. 3, p. 317
    By:
    • Moreira, A. William;
    • Southcott, Richard F.;
    • Henley, David G.;
    • Walsh, Kimberley A.
    Publication type:
    Article
    50